Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Khalaf Kridin. (2018) Emerging treatment options for the management of pemphigus vulgaris. Therapeutics and Clinical Risk Management 14, pages 757-778.
Read now
Read now
Maulik M. Dhandha, Kristina Seiffert-Sinha & Animesh A. Sinha. (2012) Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris. Autoimmunity 45:7, pages 516-526.
Read now
Read now
Animesh A. Sinha. (2012) Constructing immunoprofiles to deconstruct disease complexity in pemphigus. Autoimmunity 45:1, pages 36-43.
Read now
Read now
Mandy E Schram, Phyllis I Spuls & Jan D Bos. (2010) Off-label use of efalizumab in dermatology. Expert Review of Dermatology 5:5, pages 535-547.
Read now
Read now
Nesrin Gulez, Nesrin Gulez, Neslihan Edeer Karaca, Nesrin Gulez, Neslihan Edeer Karaca, Guzide Aksu, Nesrin Gulez, Neslihan Edeer Karaca, Guzide Aksu & Necil Kutukculer. (2009) Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations. Autoimmunity 42:1, pages 74-79.
Read now
Read now
Sara E. Billet, Sergei A. Grando & Mark R. Pittelkow. (2006) Paraneoplastic autoimmune multiorgan syndrome: Review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 39:7, pages 617-630.
Read now
Read now
Articles from other publishers (17)
Nika Kianfar, Shayan Dasdar, Ali Salehi Farid, Kamran Balighi, Hamidreza Mahmoudi & Maryam Daneshpazhooh. (2022) Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?. Frontiers in Medicine 9.
Crossref
Crossref
Maria L. Mihailescu, Bruce E. Brockstein, Nisha Desai & Jason Waldinger. (2020) Successful reintroduction and continuation of nivolumab in a patient with immune checkpoint inhibitor-induced bullous pemphigoid. Current Problems in Cancer: Case Reports 2, pages 100031.
Crossref
Crossref
Salma Assil, Robert Rissmann & Martijn Bastiaan Adriaan van Doorn. 2020. Translational Studies on Inflammation. Translational Studies on Inflammation.
Khalaf Kridin, Christine Ahn, William C. Huang, Ahmed Ansari & Naveed Sami. (2019) Treatment Update of Autoimmune Blistering Diseases. Dermatologic Clinics 37:2, pages 215-228.
Crossref
Crossref
Hui Zhang, Zheng Wang, Liqun Dong, Yannan Guo, Jin Wu & Songhui Zhai. (2016) New insight into the pathogenesis of minimal change nephrotic syndrome: Role of the persistence of respiratory tract virus in immune disorders. Autoimmunity Reviews 15:7, pages 632-637.
Crossref
Crossref
Di Kang, Bowen Li, Lei Luo, Wenbing Jiang, Qiumin Lu, Mingqing Rong & Ren Lai. (2016) Curcumin shows excellent therapeutic effect on psoriasis in mouse model. Biochimie 123, pages 73-80.
Crossref
Crossref
Z. A. Miller, K. P. Rankin, N. R. Graff-Radford, L. T. Takada, V. E. Sturm, C. M. Cleveland, L. A. Criswell, P. A. Jaeger, T. Stan, K. A. Heggeli, S. C. Hsu, A. Karydas, B. K. Khan, L. T. Grinberg, M. L. Gorno-Tempini, A. L. Boxer, H. J. Rosen, J. H. Kramer, G. Coppola, D. H. Geschwind, R. Rademakers, W. W. Seeley, T. Wyss-Coray & B. L. Miller. (2013) TDP-43 frontotemporal lobar degeneration and autoimmune disease. Journal of Neurology, Neurosurgery & Psychiatry 84:9, pages 956-962.
Crossref
Crossref
N. S. Tekin, Y. Ustundag, I. O. Tekin, R. Koca & H. C. Altinyazar. (2010) Early administration of ultraviolet treatment is effective in pegylated interferon alpha-induced severe acute exacerbation of psoriasis: a case report and short review of the literature. International Journal of Clinical Practice 64:1, pages 101-103.
Crossref
Crossref
H. Nakamura, T. Usa, M. Motomura, T. Ichikawa, K. Nakao, E. Kawasaki, M. Tanaka, K. Ishikawa & K. Eguchi. (2014) Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. Journal of Endocrinological Investigation 31:10, pages 861-865.
Crossref
Crossref
Michela Manni & Georges J.M. Maestroni. (2008) Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: Involvement of β-adrenoceptors and relevance in inflammatory diseases. Brain, Behavior, and Immunity 22:1, pages 80-88.
Crossref
Crossref
Juan Román, Alberto Fernández de Arriba, Sonia Barrón, Pedro Michelena, Marta Giral, Manuel Merlos, Elvira Bailón, Mònica Comalada, Julio Gálvez, Antonio Zarzuelo & Isabel Ramis. (2007) UR-1505, a New Salicylate, Blocks T Cell Activation through Nuclear Factor of Activated T Cells. Molecular Pharmacology 72:2, pages 269-279.
Crossref
Crossref
H Donmez-Altuntas, Z Sut, A Ferahbas, Z Hamurcu & H Demirtas. (2007) Increased micronucleus frequency in phytohaemagglutinin-stimulated blood cells of patients with vitiligo. Journal of the European Academy of Dermatology and Venereology 0:0, pages 070712005557005-???.
Crossref
Crossref
Aspasia S. Soultati, Spyridon P. Dourakis, Katerina Asvesti, Vasiliki Nezi, Alexandra Alexopoulou & Athanasios J. Archimandritis. (2007) Autoimmune Blistering Disease in a Patient with Graves Disease and Vitiligo. The American Journal of the Medical Sciences 333:5, pages 309-312.
Crossref
Crossref
John J. Bright. 2007. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease
425
451
.
Joo Chuan Tong, Tin Wee Tan, Animesh A Sinha & Shoba Ranganathan. (2006) Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6- associated Pemphigus vulgaris. BMC Bioinformatics 7:S5.
Crossref
Crossref
. (2006) Current World Literature. Current Opinion in Allergy & Clinical Immunology 6:5, pages 390-398.
Crossref
Crossref
Stephen C. Pflugfelder. (2006) Integrating Restasis into the Management of Dry Eye. International Ophthalmology Clinics 46:4, pages 101-103.
Crossref
Crossref